Skip to main content

. 1985 Aug 31;291(6495):573–574. doi: 10.1136/bmj.291.6495.573

Plasminogen activator inhibitor in the blood of patients with coronary artery disease.

J A Paramo, M Colucci, D Collen, F van de Werf

PMCID: PMC1418240 PMID: 3929877

573

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Chakrabarti R., Hocking E. D., Fearnley G. R., Mann R. D., Attwell T. N., Jackson D. Fibrinolytic activity and coronary-artery disease. Lancet. 1968 May 11;1(7550):987–990. doi: 10.1016/s0140-6736(68)91104-5. [DOI] [PubMed] [Google Scholar]
Collen D. Mechanisms of inhibition of tissue-type plasminogen activator in blood. Thromb Haemost. 1983 Oct 31;50(3):678–678. [PubMed] [Google Scholar]
Colucci M., Paramo J. A., Collen D. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest. 1985 Mar;75(3):818–824. doi: 10.1172/JCI111777. [DOI] [PMC free article] [PubMed] [Google Scholar]
Juhan-Vague I., Moerman B., De Cock F., Aillaud M. F., Collen D. Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions. Thromb Res. 1984 Mar 1;33(5):523–530. doi: 10.1016/0049-3848(84)90018-5. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES